infecti
bronchiti
viru
ibv
newcastl
diseas
viru
ndv
two
poultri
pathogen
serious
affect
poultri
industri
ibv
ectodomain
ndv
f
protein
separ
link
transmembran
carboxytermin
domain
ibv
protein
tmct
compos
rs
rf
thu
novel
chimer
infecti
bronchitisnewcastl
diseas
ibnd
viruslik
particl
vlp
vaccin
contain
rs
rf
ibv
protein
construct
transmiss
electron
microscop
tem
vlp
possess
similar
morpholog
natur
ibv
observ
evalu
immunogen
chimer
ibnd
vlp
specif
pathogenfre
spf
chicken
immun
three
increas
dose
protein
vlp
result
elisa
detect
ibv
ndv
specif
antibodi
cell
cytokin
indic
vaccin
chimer
ibnd
vlp
could
effici
induc
humor
cellular
immun
respons
challeng
studi
chimer
ibnd
vlp
protein
provid
protect
ibv
ndv
virul
challeng
death
viral
rna
level
tissu
swab
greatli
reduc
collect
chimer
ibnd
vlp
highli
immunogen
could
provid
complet
protect
ibv
ndv
virul
challeng
chimer
ibnd
vlp
appeal
vaccin
candid
promis
vaccin
platform
bear
multival
antigen
avian
infecti
bronchiti
ib
newcastl
diseas
nd
common
highli
contagi
acut
avian
diseas
caus
heavi
loss
poultri
industri
infecti
bronchiti
viru
ibv
pathogen
ib
member
gammacoronaviru
coronavirida
famili
http
wwwictvglob
genom
ibv
kb
length
encod
fifteen
nonstructur
protein
four
structur
protein
spike
glycoprotein
small
membran
protein
e
membran
glycoprotein
phosphoryl
nucleocapsid
protein
n
glycoprotein
abund
protein
viral
envelop
perform
core
function
process
coronaviru
assembl
bud
furthermor
protein
gener
consid
essenti
compon
format
coronaviruslik
particl
covlp
glycoprotein
ibv
ndv
la
sota
strain
store
c
anim
diseas
prevent
food
safeti
key
laboratori
sichuan
provinc
sichuan
univers
propag
embryon
spf
egg
boehring
ingelheim
vital
biotechnolog
co
ltd
beij
china
use
previous
describ
cell
cultur
iii
sfm
gibco
grand
island
ny
usa
c
rna
virus
extract
trizol
invitrogen
carlsbad
ca
usa
subsequ
cdna
synthet
use
superscript
iii
firststrand
synthesi
system
takara
kyoto
japan
follow
manufactur
instruct
briefli
revers
transcript
reaction
mixtur
consist
primescript
buffer
primescript
rt
enzym
mix
oligo
dt
primer
random
mer
rna
viru
rnase
free
thu
creat
final
volum
tmct
amplifi
ibv
cdna
f
ecto
amplifi
ndv
la
sota
cdna
f
ecto
individu
link
tmct
digestionlig
thu
form
rs
rf
gene
figur
make
three
domain
function
natur
sequenc
encod
short
flexibl
peptid
glyglysers
insert
fusion
site
sequenc
primer
use
step
list
tabl
underlin
sequenc
cleavag
site
restrict
enzym
cgc
box
protect
base
ital
tcc
tca
insert
codon
tcc
revers
complement
glycin
codon
gga
glycin
gli
tca
encod
serin
ser
codon
togeth
ggatcc
bamh
site
encod
flexibl
peptid
glyglysers
genom
posit
primer
list
accord
complet
genom
sequenc
ibv
ndv
la
sota
rs
rf
gene
individu
clone
peasi
vector
transgen
beij
china
subsequ
rs
individu
subclon
plasmid
invitrogen
carlsbad
ca
usa
ecor
ihind
iii
site
rf
subclon
sal
ihind
iii
site
figur
recombin
vector
chemic
transform
tm
e
coli
invitrogen
carlsbad
ca
usa
gener
recombin
bacmid
rbm
posit
clone
verifi
bluewhit
select
sequenc
use
primer
rbmrf
rbmr
rbmm
purifi
purelink
tm
hipur
plasmid
dna
miniprep
kit
invitrogen
carlsbad
ca
usa
accord
manufactur
instruct
purifi
rbm
cellfectin
ii
reagent
individu
dilut
grace
medium
afterward
dilut
dna
dilut
cellfectin
ii
combin
make
rbm
packag
lipidosom
incub
min
transfect
mixtur
ad
dropwis
onto
cell
cultur
plate
densiti
per
well
incub
c
h
transfect
mixtur
replac
ml
ii
smf
gibco
grand
island
ny
usa
sign
viral
infect
observ
h
post
transfect
cell
frozenandthaw
twice
releas
recombin
baculovirus
rbv
cultur
medium
collect
centrifug
g
min
remov
cell
debri
thu
first
passag
rbvrf
rbvr
rbvm
obtain
titer
rbv
determin
plaqu
assay
accord
manual
baculoviru
system
invitrogen
carlsbad
ca
usa
express
target
protein
cell
separ
infect
third
passag
rbvrf
rbvr
rbvm
titer
pfuml
multipl
infect
moi
seventytwo
hour
postinfect
cell
pellet
lyse
ripa
beyotim
shanghai
china
cytolysatetogeth
supernat
cultur
mediawer
analyz
western
blot
rabbit
polyclon
sera
ibv
use
primari
antibodi
detect
rs
rabbit
antinewcastl
diseas
polyclon
antibodi
absin
bioscienc
shanghai
china
use
detect
rf
antirabbit
igg
hrplink
antibodi
use
secondari
antibodi
band
visual
use
dab
substrat
kit
solarbio
beij
china
follow
manufactur
instruct
vlp
product
cell
coinfect
rbvrf
rbvr
rbvm
moi
h
cultur
medium
collect
centrifug
g
min
c
remov
cell
debri
subsequ
supernat
ultracentrifug
g
h
c
resuspend
sediment
pb
solut
load
wv
discontinu
sucros
gradient
ultracentrifug
g
h
c
purifi
vlp
interfac
collect
purif
vlp
could
harvest
ml
cultur
medium
sdspage
perform
analyz
vlp
sampl
protein
stain
coomassi
brilliant
blue
cbb
total
protein
concentr
vlp
inactiv
ibv
inactiv
ndv
determin
bradford
protein
assay
kit
beyotim
shanghai
china
concentr
rs
rf
protein
vlp
protein
inactiv
ibv
f
protein
inactiv
ndv
determin
densitometri
cbbstain
sdspage
gel
bsa
standard
observ
chimer
ibnd
vlp
purifi
vlp
load
onto
carbonco
copper
grid
min
negativelystain
wv
phosphotungst
acid
min
view
tem
tecnai
stwin
hillsboro
usa
first
anim
studi
spf
chicken
boehring
ingelheim
vital
biotechnolog
co
ltd
beij
china
randomli
divid
group
chicken
per
group
chicken
group
immun
vlp
contain
total
protein
rs
rf
per
chicken
chicken
group
immun
vlp
contain
total
protein
rs
rf
per
chicken
chicken
group
immun
vlp
contain
total
protein
rs
rf
per
chicken
chicken
group
inocul
inactiv
ibv
protein
eid
inactiv
ndv
la
sota
f
protein
eid
adjuv
via
intramuscular
rout
respect
la
sota
strain
inactiv
formaldehyd
final
concentr
c
h
chicken
group
mock
control
inject
cultur
medium
cell
infect
wildtyp
baculoviru
two
group
set
ibv
ndv
infect
control
challeng
studi
daypostprimaryvaccin
dpv
boost
vaccin
perform
program
dose
primari
vaccin
dpv
chicken
odd
group
intranas
challeng
eid
ibv
chicken
even
group
intranas
challeng
eid
ndv
second
anim
studi
measur
viral
rna
level
tissu
spf
chicken
randomli
divid
group
n
immun
challeng
program
first
studi
first
anim
studi
chicken
bled
measur
ibv
ndv
specif
antibodi
titer
dpv
serum
sampl
dpv
also
use
detect
concentr
oral
swab
collect
surviv
anim
dpv
monitor
viru
shed
challeng
chicken
observ
daili
day
check
clinic
symptom
second
anim
studi
daypostchalleng
dpc
surviv
chicken
sacrif
get
tissu
sampl
quantif
replic
challeng
virus
lung
trachea
spleen
kidney
small
intestin
taken
determin
ibv
rna
level
lung
trachea
spleen
brain
small
intestin
taken
ndv
rna
level
determin
anim
experi
studi
approv
anim
ethic
committe
ace
colleg
life
scienc
sichuan
univers
licens
experi
procedur
anim
welfar
standard
strictli
follow
guidelin
anim
manag
sichuan
univers
ibvspecif
antibodi
serum
detect
infecti
bronchiti
viru
antibodi
test
kit
idexx
westbrook
usa
ndv
antibodi
detect
newcastl
diseas
viru
antibodi
test
kit
idexx
westbrook
usa
concentr
serum
individu
monitor
use
elisa
kit
interleukin
cloudclon
houston
tx
usa
elisa
kit
interferon
gamma
cloudclon
houston
tx
usa
accord
manufactur
instruct
evalu
viral
rna
level
tissu
g
tissu
sampl
use
rna
isol
swab
suspend
ml
pb
subsequ
supernat
sampl
use
extract
rna
evalu
viral
rna
level
swab
revers
transcript
total
volum
revers
transcript
product
ie
onetenth
total
rna
use
templat
absolut
quantif
realtim
pcr
qpcr
determin
ibv
ndv
copi
number
use
ssofast
tm
evagreen
supermix
biorad
berkeley
ca
usa
primer
design
via
primer
premier
version
premier
inc
palo
alto
ca
usa
accord
genom
sequenc
ibv
genbank
access
ndv
genbank
access
primer
sequenc
follow
ibsens
ibantisens
ndsens
ndantisens
qpcr
carri
quadrupl
statist
signific
differ
serolog
viral
rna
level
analys
group
evalu
student
ttest
graphpad
prism
version
graphpad
softwar
inc
la
jolla
ca
usa
differ
consid
signific
p
p
kda
band
band
kda
separ
detect
antiibv
sera
rbvr
rbvm
infect
sampl
approxim
kda
band
detect
antindv
antibodi
rbvrf
infect
sampl
result
show
rs
rf
protein
could
express
current
condit
figur
addit
predict
size
rs
rf
protein
kda
kda
kda
respect
accord
result
western
blot
rs
protein
express
studi
larger
predict
rf
protein
similar
predict
seiz
indic
rs
might
glycosyl
rf
might
glycosyl
purifi
vlp
analyz
sdspage
three
distinct
protein
band
observ
kda
band
correspond
rs
kda
band
correspond
rf
kda
band
correspond
figur
tem
morpholog
chimer
ibnd
vlp
observ
shown
figur
chimer
vlp
appear
spheric
particl
diamet
nm
similar
nativ
ibv
dpv
level
ibvand
ndvspecif
antibodi
serum
evalu
indirect
elisa
dpv
significantli
higher
mean
ibvand
ndvspecif
antibodi
titer
serum
immun
chicken
mock
chicken
observ
p
figur
mean
antibodi
titer
appar
increas
follow
boost
vaccin
antibodi
level
induc
vlp
show
dosedepend
increas
within
current
immun
dose
rang
comparison
vlp
inactiv
vaccin
group
contain
similar
dose
antigen
protein
vlp
versu
sota
signific
differ
observ
abil
chimer
ibnd
vlp
induc
cellular
immun
respons
investig
measur
concentr
serum
immun
chicken
dpv
figur
show
mean
concentr
serum
chicken
vaccin
group
significantli
higher
compar
mock
group
p
furthermor
vlp
induc
higher
level
inactiv
vaccin
especi
dpv
level
serum
chicken
vlp
group
significantli
higher
two
inactiv
vaccin
group
p
figur
signific
level
detect
serum
inactiv
vaccinesinject
chicken
compar
serum
chicken
mock
group
indic
two
inactiv
vaccin
fail
induc
product
figur
contrast
vlp
stimul
significantli
higher
level
inactiv
vaccin
p
first
anim
studi
chicken
challeng
virul
ibv
ndv
strain
kept
day
observ
clinic
symptom
monitor
viru
shed
oral
swab
virul
ibv
strain
challeng
chicken
show
appar
symptom
vlp
group
includ
depress
huddl
chicken
die
dpc
respect
vlp
group
chicken
show
symptom
die
dpc
chicken
vlp
group
show
complet
resist
virul
ibv
challeng
appar
symptom
observ
contrast
chicken
mock
group
show
symptom
show
sever
depress
final
chicken
surviv
figur
ndv
challeng
chicken
vlp
group
show
symptom
show
neurolog
sign
chicken
die
within
day
vlp
group
chicken
show
neurolog
sign
die
dpc
chicken
vlp
group
show
symptom
chicken
surviv
chicken
inla
sota
group
observ
mild
depress
chicken
die
chicken
mock
group
show
sever
depress
neurolog
sign
die
within
day
figur
virus
dpv
figur
show
mean
concentr
serum
chicken
vaccin
group
significantli
higher
compar
mock
group
p
furthermor
vlp
induc
higher
level
inactiv
vaccin
especi
dpv
level
serum
chicken
vlp
group
significantli
higher
two
inactiv
vaccin
group
p
figur
signific
level
detect
serum
inactiv
vaccinesinject
chicken
compar
serum
chicken
mock
group
indic
two
inactiv
vaccin
fail
induc
product
figur
contrast
vlp
stimul
significantli
higher
level
inactiv
vaccin
p
first
anim
studi
chicken
challeng
virul
ibv
ndv
strain
kept
day
observ
clinic
symptom
monitor
viru
shed
oral
swab
virul
ibv
strain
challeng
chicken
show
appar
symptom
vlp
group
includ
depress
huddl
chicken
die
dpc
respect
vlp
group
chicken
show
symptom
die
dpc
chicken
vlp
group
show
complet
resist
virul
ibv
challeng
appar
symptom
observ
contrast
chicken
mock
group
show
symptom
show
sever
depress
final
chicken
surviv
figur
ndv
challeng
chicken
vlp
group
show
symptom
show
neurolog
sign
chicken
die
within
day
vlp
group
chicken
show
neurolog
sign
die
dpc
chicken
vlp
group
show
symptom
chicken
surviv
chicken
inla
sota
group
observ
mild
depress
chicken
die
chicken
mock
group
show
sever
depress
neurolog
sign
die
within
day
figur
oral
swab
collect
dpc
viral
rna
level
monitor
figur
show
mean
ibv
rna
level
swab
chicken
immun
group
reduc
differ
degre
compar
mock
group
five
time
point
dpc
mean
ibv
rna
level
swab
chicken
vlp
group
significantli
lower
mock
group
p
dpc
mean
ibv
rna
level
swab
vlp
vlp
significantli
reduc
compar
mock
group
p
last
three
time
point
mean
ibv
rna
level
swab
vaccin
group
significantli
lower
mock
group
p
furthermor
mean
ibv
rna
level
swab
vlp
group
significantli
lower
group
dpc
p
ndv
mean
rna
level
swab
vlp
group
significantli
lower
mock
group
dpc
mean
ndv
rna
level
swab
vaccin
group
significantli
lower
mock
group
dpc
last
three
time
point
differ
analys
swab
immun
chicken
mock
chicken
conduct
chicken
die
mock
group
figur
furthermor
dpc
mean
ndv
rna
level
swab
vlp
group
significantli
lower
inla
sota
group
p
dpc
differ
mean
ndv
rna
level
swab
vlp
inla
sota
signific
p
second
anim
studi
ibv
ndv
rna
level
tissu
measur
dpc
gener
mean
ibv
rna
level
tissu
chicken
immun
group
significantli
reduc
compar
mock
group
p
furthermor
mean
ibv
rna
level
trachea
chicken
vlp
significantli
lower
p
figur
ndv
challeng
studi
chicken
mock
group
die
dpc
differ
analys
conduct
vlp
inla
sota
group
mean
ndv
rna
level
lung
small
intestin
chicken
vlp
significantli
lower
inla
sota
p
mean
ndv
rna
level
trachea
chicken
vlp
group
significantli
lower
inla
sota
group
figur
ibv
ndv
f
protein
promis
candid
antigen
develop
novel
recombin
vaccin
prove
two
protein
abl
provid
effici
protect
ibv
ndv
virul
challeng
vaccin
multival
vaccin
potenti
advantag
reduc
cost
labor
convent
live
inactiv
vaccin
ibv
ndv
wide
use
field
nevertheless
live
inactiv
vaccin
obviou
shortcom
mutant
genom
virus
live
vaccinesa
well
recombin
vaccin
virus
wild
virusescould
caus
emerg
novel
strain
result
diseas
vaccin
individu
addit
ndv
live
vaccin
sometim
caus
mild
clinic
symptom
inactiv
vaccin
thought
safer
live
vaccin
howev
potenti
incomplet
inactiv
viru
could
also
caus
diseas
vaccin
individu
besid
inactiv
vaccin
effect
stimul
cellular
respons
better
control
ibv
ndv
sever
novel
vaccin
virus
develop
among
revers
genet
vaccin
highprofil
particularli
ndv
revers
genet
vaccin
live
inactiv
licens
use
field
howev
safeti
still
major
concern
revers
genet
vaccin
mention
revers
genet
strain
use
live
vaccin
mutantsa
well
recombinationar
like
result
emerg
novel
strain
contrast
lack
viral
rna
make
vlp
noninfecti
elimin
possibl
mutant
recombin
wild
strain
could
happen
live
vaccin
use
moreov
compar
inactiv
vaccin
vlp
similar
infecti
virus
term
structur
morpholog
vlp
could
induc
stronger
immun
respons
inactiv
vaccin
vlp
consid
suitabl
multival
vaccin
platform
rna
virus
high
mutat
rate
protein
prove
essenti
construct
covlp
order
make
ndv
f
protein
interact
ibv
protein
take
part
construct
vlp
tmct
domain
f
protein
replac
ibv
protein
thu
form
rf
protein
afterward
coexpress
ibv
rs
protein
ndv
rf
protein
insect
cell
result
gener
spheric
particl
possess
similar
size
shape
nativ
ibv
sdspage
analysi
purifi
spheric
particl
show
compos
rs
rf
protein
indic
chimer
ibnd
vlp
bear
ibv
ndv
antigen
success
produc
figur
investig
whether
chimer
ibnd
vlp
effici
induc
immun
respons
purifi
vlp
inject
chicken
antibodi
cytokin
serum
measur
induc
humor
immun
respons
chimer
ibnd
vlp
could
effect
induc
ibvand
ndvspecif
antibodi
even
without
adjuv
vlp
induc
compar
antibodi
level
inactiv
vaccin
adjuv
nonrepl
vaccin
adjuv
serv
critic
compon
elicit
adequ
immun
respons
vlp
possess
similar
morpholog
nativ
virus
effici
taken
antigen
present
cell
process
way
nativ
virus
without
adjuv
cellular
immun
respons
induct
significantli
higher
level
mock
group
demonstr
abil
chimer
ibnd
vlp
evok
cellular
immun
respons
figur
contrast
inactiv
vaccin
induc
signific
level
compar
mock
group
cellular
immun
respons
induc
due
structur
morpholog
similar
infecti
virus
abil
bind
penetr
host
cell
vlp
could
induc
stronger
cellular
immun
respons
inactiv
vaccin
qualiti
vaccin
abl
prevent
pathogen
transmiss
data
show
ibv
shed
effici
suppress
vaccin
group
compar
mock
group
five
time
point
ndv
shed
also
effici
suppress
dpc
figur
addit
significantli
lower
mean
ibv
rna
level
swab
vlp
compar
group
observ
dpc
p
figur
mean
ndv
rna
level
differ
vlp
inla
sota
individu
signific
p
signific
p
dpc
tissu
challeng
chicken
mean
ibv
rna
level
trachea
mean
ndv
titer
lung
trachea
small
intestin
chicken
immun
vlp
lower
chicken
immun
inactiv
vaccin
signific
signific
differ
observ
result
indic
vlp
perform
better
inactiv
vaccin
gener
consid
stronger
humor
cellular
immun
result
less
viru
replic
antibodi
level
serum
chicken
vlp
compar
inactiv
vaccin
group
lower
viru
titer
vlp
group
due
stronger
cellular
immun
respons
induc
vlp
line
result
detect
cytokin
serum
vlp
abl
evok
respons
inactiv
vaccin
evok
respons
mix
respons
gener
consid
prefer
prevent
treat
viral
infect
addit
multival
display
highli
order
structur
present
surfac
vlp
thought
kind
pathogen
associ
molecular
pattern
pamp
recogn
tolllik
receptor
tlr
patternrecognit
receptor
prr
result
increas
immunogen
due
high
level
humor
cellular
respons
induc
vlp
observ
chicken
immun
vlp
die
symptom
observ
ibv
ndv
virul
challeng
thu
indic
chimer
ibnd
vlp
abl
provid
complet
protect
chicken
taken
togeth
data
indic
chimer
ibnd
vlp
abl
simultan
induc
ibvand
ndvantibodi
level
compar
induc
singl
ibv
ndv
inactiv
vaccin
adjuv
chimer
ibnd
vlp
perform
better
induc
cellular
respons
suppress
viru
replic
inactiv
vaccin
studi
chimer
ibnd
vlp
construct
use
ibv
protein
two
recombin
protein
ie
rs
rf
use
vaccin
chimer
ibnd
vlp
abl
effici
induc
humor
cellular
immun
respons
compar
inactiv
vaccin
chimer
ibnd
vlp
perform
better
term
induc
cellular
respons
suppress
viru
replic
conclus
studi
indic
ib
vlp
use
molecular
platform
genet
fusion
heterolog
antigen
studi
also
suggest
promis
chimer
ibnd
vlp
appeal
vaccin
candid
could
simultan
prevent
ibv
ndv
